(Q36698125)

15 August 2017

1 reference

title

Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes (English)

1 reference

15 August 2017

Cuzzocrea S

1

1 reference

15 August 2017

Salvemini D

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

3 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

71

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

290-297

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002058

15 August 2017

exact match

0 references

cites work

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide: a novel mediator of inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Prostaglandin endoperoxide synthase: regulation of enzyme expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide activates cyclooxygenase enzymes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Regulation of prostaglandin production by nitric oxide; an in vivo analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

NMDA-dependent prostaglandin E2 release by human cultured astroglial cells is driven by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Spontaneous induction of nitric oxide- and prostaglandin E2-release by hypoxic astroglial cells is modulated by interleukin 1 beta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

A magic bullet for mucosal protection...and aspirin is the trigger!

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Renal papillary necrosis induced by naproxen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Cyclooxygenase-2 inhibitors: is there an association with coronary or renal events?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

COX-inhibiting nitric oxide donors (CINODs): potential benefits on cardiovascular and renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The effects of nitric oxide on prostanoid production and release by human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Modulation by nitric oxide of prostaglandin biosynthesis in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Prostanoid generation in early stages of acute pancreatitis: a role for nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric Oxide Activates the Cyclooxygenase Pathway in Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inhibition of nNOS expression in the macula densa by COX-2-derived prostaglandin E(2).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Interaction between nitric oxide and prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Regulation of prostaglandin H2 synthase activity by nitrogen oxides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Kinetics of peroxynitrite reaction with amino acids and human serum albumin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide stimulates cyclooxygenase-2 in cultured cTAL cells through a p38-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

The dual personality of NO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

IL-1-induced iNOS expression in human astrocytes via NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Inhibition of NF-kappaB DNA binding by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Differential effects of nitric oxide–mediated S-nitrosylation on p50 and c-jun DNA binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002058

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002058

1 reference

15 August 2017

1 reference